Featured

• Heart-on-a-Chip Technology Predicts Preclinical Systolic and Diastolic in vivo Observations for Novel Cardiac Drug in Development

  NEW YORK, NY (Newswire.com)—TARA Biosystems, Inc. today reported in vivo and in vitro functional data from a study of investigational candidate, MYK-491, showing that TARA’s human iPSC-derived organ-on-a-chip technology can directly measure in vivo cardiac performance.  These data will be presented today at the American Heart Association’s Scientific Sessions in Philadelphia.  MYK-491 is MyoKardia, Inc.’s …